Artigo Revisado por pares

Incremental value of exercise echocardiography over exercise electrocardiography in a chest pain unit

2015; Elsevier BV; Volume: 26; Issue: 9 Linguagem: Inglês

10.1016/j.ejim.2015.08.002

ISSN

1879-0828

Autores

Alberto Bouzas‐Mosquera, Jesús Peteiro, Francisco J. Broullón, Nemesio Álvarez‐García, Jorge Rodríguez-Garrido, Víctor X. Mosquera, Dolores Martínez, Juan C. Yáñez, José Manuel Vázquez‐Rodríguez,

Tópico(s)

Cardiac electrophysiology and arrhythmias

Resumo

Limited data are available on the added value of exercise echocardiography (ExEcho) over exercise electrocardiography (ExECG) in patients with suspected acute coronary syndromes (ACS) referred to a chest pain unit. We aimed to assess the incremental value of ExEcho over ExECG in this setting.ExECG and ExEcho were performed in parallel in 1052 patients with suspected ACS, nondiagnostic but interpretable electrocardiograms, and negative serial troponin results. The primary outcome was a composite of coronary death, nonfatal myocardial infarction or unstable angina with angiographic documentation of significant coronary artery disease within 6 months.The primary outcome occurred in 2/614 patients (0.3%) with both negative ExECG and ExEcho, 3/60 (5%) with positive ExECG and negative ExEcho, 73/135 (54.1%) with negative ExECG and positive ExEcho, 106/136 (77.9%) with both positive ExECG and ExEcho, and 8/107 (7.5%) with inconclusive results. The addition of ExEcho data to a model based on clinical and ExECG data significantly increased the c statistic from 0.898 to 0.968 (change +0.070, 95% confidence interval 0.052-0.092), with a continuous net reclassification improvement of 1.56 and an integrated discrimination improvement of 22% (p<0.001). Decision curve analysis showed that a strategy of referral to coronary angiography based on ExEcho was associated with the highest net benefit and with the largest reduction in unnecessary coronary angiographies.ExEcho provides significant incremental prognostic information and higher net clinical benefit than a strategy based on ExECG in patients referred to a chest pain unit for suspected ACS and negative troponin levels.

Referência(s)